Whittier, J.R. , and Dhrymiotis, A.D.: Effect of cyclandelate, isoxsuprine and nylidrin on hyperventilation build-up in the EEG of volunteer subjects . Angiology, 16: 575, 1965.
2.
Korein, J., Geller, M., Rosenblum, W.I., and Levidow, L.: Effects of a vasoactive drug (Nylidrin HCl) on the response of the electroencephalogram to hyperventilation. Arch. Neurol. & Psychiat., 14: 202, 1966.
3.
Kiloh, L.G., and Osselton, J.W.: Clinical Electroencephalography, p. 21. Butterworths, London , 1961.
4.
Ernsting, M.J.E. , Rekker, R.F., Tersteege , H.M., and Nauta, W.T.: Investigation on spasmolytics. VII. The metabolism of 3,5,5-trimethylcyclohexylmandelate (Cyclandelate). II. Arztl. Forsch., 12: 632, 1962.
5.
Ernsting, M.J. , Rekker, R.F., Tersteege , H.M., and Nauta, W.T.: Investigation on spasmolytics. IX. The metabolism of 3,5,5-trimethylcyclohexylmandelate (Cyclandelate). IV. Arztl. Forsch., 12: 853, 1962.
6.
Kappert, A.: The treatment of peripheral circulatory disturbances with cyclospasmol . Schweiz. med. Wchnschr., 85: 237, 1966.
7.
O'Brien, M.D. , and Veall, N.: Effect of cyclandelate on cerebral cortex perfusion-rates in cerebrovascular disease. Lancet , 729, 1966.
8.
Fremont, R.E.: Current approach to arterial occlusive disease. Exhibit presented before the American Medical Association Convention, New York City, June 20-24, 1965.
9.
Gentili, C., Lugaresi, E., and Rebucci, G.G.: Sull'azione di un prodotto di esterificazione dell'acido mandelico con it 3,5,5-trimethilcidoesanole sul circolo cerebrale (Ciclospasmol). Clin. terap., 22: 803, 1962.
10.
Funcke, A.B.H. : Pharmacological investigations on the spasmolytic activity of a series of mandelic acid esters, especially the ester of 3,5,5-trimethylcyclohexanol (Cyclospasmol). Academic ThesisVrije Universiteit, Amsterdam, 1952.
11.
Ward, P.J.: A clinical study of a spasmolytic agent (Cyclospasmol) in the treatment of elderly arteriosclerotic patients. Ulster M. J., 34: 129, 1965.
12.
Luisada, A.A. , Jacobs, R., Bruce , D., Berstein, J., and MacCanon, C.M.: Action of a vasodilator on the circulation of the skull and brain. Vas. Dis., 3: 201, 1966.
13.
Hornstein, L.S.: Clinical results with high doses of cyclandelate . J. Vas. Dis., 12: 435, 1961.
14.
Brodie, B.B. : Physicochemical and biochemical aspects of pharmacology. J. A. M. A., 202: 600, 1967.
15.
Brodie, B.B. , and Reid, W.D.: Some pharmacological consequences of species variation in rates of metabolism. Fed. Proc., 26: 1062, 1967.